Auron Therapeutics Makes Strides in KAT2A/B Program and Secures $27 Million in Series B Financing

Auron Therapeutics achieves progress in key program and secures significant funding round

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here